期刊文献+

腺病毒载体介导的HBx表达对HepG2细胞中PPARγ定位的影响 被引量:3

Effects of HBx on localization of PPARγ in HepG2 cell line
下载PDF
导出
摘要 目的检测外源基因HBx转入HepG2细胞后对PPARγ表达定量及定位的影响。方法以HBx重组腺病毒感染HepG2细胞,分别用RT-PCR和总蛋白Western blot检测PPARγ表达量的改变,免疫细胞化学检测其定位改变,Western blot分别检测细胞质和细胞核中PPARγ蛋白量的表达改变,MTT法检测HBx对曲格列酮抑制HepG2增殖效率的影响。结果外源基因HBx转入HepG2细胞后,RT-PCR、总蛋白Western blot显示PPARγ表达差异无统计学意义(P>0.05),免疫细胞化学及细胞质和细胞核中PPARγ蛋白检测提示PPARγ在细胞核内表达降低而在细胞质中出现积聚,曲格列酮对HepG2细胞增殖的抑制效率降低(P<0.05)。结论外源基因HBx对HepG2细胞中PPARγ的表达量无明显影响,但影响其向核内转移。HBx降低曲格列酮对HepG2细胞增殖的抑制效率。 Objective Hepatitis B virus (HBV)-encoded X (HBx) contributes to the development of hepatocellular carcinoma (HCC). Peroxisome proliferator activated receptor (PPARγ) highly expressed in some hepatoma cell lines. We tend to investigate the possible relationship between HBx and PPARγ in the development of hepatic cancer. Methods PPARγof HepG2 cells traysinfected with recombinant HBx adenovirus, with blank vector and without transfection was detected by RT-PCR for its mRNA level, Western blot for its protein level and immunocytochemistry for its localization. The effect of HBx on the inhibition of HepG2 cell growth by troglitazone, the ligand of PPARγ, was measured by MTT assay. Results The localization of PPARγ in HepG2 cells infected with HBx adenovirus was changed, increasing in cytoplasm and decreasing in cellular nucleus, while the expressions of PPARγmRNA and protein were not significantly changed, compared with those in HepG2 cells or HepG2 cells transfected with blank vector. The inhibitory effects of troglitazone on HepG2 cell growth weakened when HepG2 cells were infected with HBx adenovirus. Conclusion HBx may affect the localization of PPARγ, but not the quantity of PPARγexpression. HBx decreases the inhibition ratio of troglitazone on HepG2 cell growth.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第18期1693-1696,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(30771925)~~
关键词 HBX HEPG2细胞 PPARΓ 曲格列酮 Hepatitis B virus-encoded X HepG2 cell Peroxisome proliferator activated receptor troglitazone
  • 相关文献

参考文献9

  • 1Feitelson M A, Reis H M, Liu J, et al. Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis[ J]. Front Biosci, 2005, 10 : 1558 - 1572.
  • 2Koga H, Harada M, Ohtsubo M, et al. Troglitazone induces p27Kipl- associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells [ J ]. Hepatology, 2003, 37 (5) .- 1086 - 1096.
  • 3Yu J, Qiao L, Zimmermann L, et al. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo[ J]. Hepatology, 2006, 43( 1 ) : 134 - 143.
  • 4梁磊,乔唐,徐永健,钱海鑫.过氧化物酶增殖物活化受体γ对肝肿瘤细胞生物学行为影响的实验研究[J].中华肝胆外科杂志,2007,13(6):402-405. 被引量:1
  • 5Okano H, Shiraki K, Inoue H, et al. Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma[ J]. Anticancer Drugs, 2002, 13 (1) : 59 - 65.
  • 6Canuto R A, Maggiora M, Trombetta A, et al. Aldehyde dehydrogenase 3 expression is decreased by clofibrate via PPAR gamma induction in JM2 rat hepatoma cell line[J]. Chem Biol Interact, 2003, 143 - 144:29-35.
  • 7Sharma C, Pradeep A, Wong L, et al. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway [J]. J Biol Chem, 2004, 279(34) : 35583 -35594.
  • 8Burns KA, Vanden-Heuvel J P. Modulation of PPAR activity via phosphorylation [ J ]. Biochim Biophys Acta, 2007, 1771 (8) : 952 - 960.
  • 9魏倩萍,邓华聪,赵劼.p38MAPK对大鼠肾小球系膜细胞表达PPAR-γ的影响[J].第三军医大学学报,2006,28(16):1659-1662. 被引量:5

二级参考文献19

  • 1GUAN Y.Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome[J].J Am Soc Nephrol,2004,15(11):2801-2815.
  • 2IGARASHI M,WAKASAKI H,TAKAHARA N,et al.Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways[J].J Clin Invest,1999,103(2):185-195.
  • 3MAKITA Z,VLASSARA H,CERAMI A,et al.Immunochemical detection of advanced glycosylation end products in vivo[J].J Boil Chem,1992,267(8):5133-5138.
  • 4MASAMUNE A,SATOH K,SAKAI Y,et al.Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells[J].Pancreas,2002,24(2):130-138.
  • 5NICHOLAS S B,KAWANO Y,WAKINO S,et al.Expression and function of peroxisome proliferator-activated receptor-gamma in mesangial cells[J].Hypertension,2001,37(2 Part 2):722-727.
  • 6YOSHIOKA M,WAKISAKA M,NAKAMURA U,et al.Peroxisome proliferator-activated receptor-gamma l and contractile response of rat mesangial cells under the high glucose condition[J].Diabetes,2001,50 (2):A468-A469.
  • 7HSUEH W A,NICHOLAS S B.Peroxisome proliferator-activated receptor-gamma in the renal mesangium[J].Curr Opin Nephrol hypertens,2002,11(2):191-195.
  • 8ESCHER P,WAHLI W.Peroxisome proliferator-activated receptors:insight into multiple cellular functions[J].Mutat Res,2000,448(2):121-138.
  • 9PURVES T,MIDDLEMAS A,AGTHONG S,et al.A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy[J].FASEB J,2001,15(13):2508-2514.
  • 10TERUEL T,HERNANDEZ R,BENITO M,et al.Rosiglitazone and retinoic acid induce uncoupling protein-1 (UCP-1) in a p38 mitogen-activated protein kinase-dependent manner in fetal primary brown adipocytes[J].J Biol Chem,2003,278(1):263-269.

共引文献4

同被引文献58

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部